RU94020614A - Antitumor agent - Google Patents
Antitumor agentInfo
- Publication number
- RU94020614A RU94020614A RU94020614/14A RU94020614A RU94020614A RU 94020614 A RU94020614 A RU 94020614A RU 94020614/14 A RU94020614/14 A RU 94020614/14A RU 94020614 A RU94020614 A RU 94020614A RU 94020614 A RU94020614 A RU 94020614A
- Authority
- RU
- Russia
- Prior art keywords
- water
- nitrosourea
- chloroethyl
- bis
- polyvinylpyrrolidone
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
FIELD: pharmacy, antitumors agents. SUBSTANCE: agent based on 1,3-bis-(2-chloroethyl)-1-nitrosourea has additionally low-molecular polyvinylpyrrolidone (molecular mass is 12600), ethanol and water at the following ratio of components, wt.-%: 1,3--bis-(2-chloroethyl)-1-nitrosourea 0.50-0.74; polyvinylpyrrolidone (molecular mass is 12600) 19-21; 95% ethanol 4.8-6.0, and water for injection up to 100. Agent can be used for treatment of malignant neoplasma. EFFECT: increased stability, safety, decreased by-side effects, preparing water-soluble medicinal form.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU94020614A RU2066181C1 (en) | 1994-06-02 | 1994-06-02 | Antitumor agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU94020614A RU2066181C1 (en) | 1994-06-02 | 1994-06-02 | Antitumor agent |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94020614A true RU94020614A (en) | 1996-08-27 |
RU2066181C1 RU2066181C1 (en) | 1996-09-10 |
Family
ID=20156724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94020614A RU2066181C1 (en) | 1994-06-02 | 1994-06-02 | Antitumor agent |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2066181C1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2699558C2 (en) * | 2018-10-05 | 2019-09-06 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ Радиологии" Минздрава России РФ) | Agent for targeted therapy of malignant growths |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998043628A1 (en) * | 1997-04-02 | 1998-10-08 | Viktor Veniaminovich Tets | Antitumoral drugs (chlonidan) |
-
1994
- 1994-06-02 RU RU94020614A patent/RU2066181C1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2699558C2 (en) * | 2018-10-05 | 2019-09-06 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ Радиологии" Минздрава России РФ) | Agent for targeted therapy of malignant growths |
Also Published As
Publication number | Publication date |
---|---|
RU2066181C1 (en) | 1996-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO863620L (en) | PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION | |
JPS63139136A (en) | Enhancer for transdermal transmission of general medicine | |
IT1261849B (en) | MEDICAL DEVICE FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS OR VERY LOW DOSAGE DRUGS, IN PARTICULAR HOMEOPATHIC DRUGS. | |
KR960704543A (en) | Parenteral Busulfan for treatment of malignant disease | |
ATE81287T1 (en) | TARGETED ENTERAL DELIVERY SYSTEM. | |
CY1111088T1 (en) | PHARMACEUTICAL FORM FOR TOLTERODIN ADMINISTRATION WITH CONTROLLED LIBERTY | |
ES2171469T3 (en) | COMPOSITION ADMINISTERED BY NASAL AND PREPARATION THAT CONTAINS IT. | |
RU96122884A (en) | HUMAN CANCER TREATMENT METHOD | |
KR970702728A (en) | Cancer Treatment and Metastasis Prevention | |
BR9912356A (en) | Treatment regimen for the administration of phenylacetylglutamine, phenylacetylisoglutamine, and / or phenylacetate | |
EP0795561A4 (en) | Novel anthracycline compound derivatives and medicinal preparations containing the same | |
KR970025615A (en) | Cancer metastasis inhibitor | |
RU95101385A (en) | Products containing g-csf and tnf-binding protein | |
US3932624A (en) | Method for prolonging the inhibitory effect of saralasin on angiotensin II | |
RU94020614A (en) | Antitumor agent | |
KR860003018A (en) | Medical treatment of non-viral diseases of human body using 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide | |
US3105793A (en) | Injectable medicinal composition | |
KR830009776A (en) | Induction of Cell Protection | |
KR870010871A (en) | Intraoperative Treatment of Basal Cell Carcinoma by Recombinant Human Alpha Interferon | |
EP0728479A1 (en) | Deacetyl moxisylyte in the treatment of acute urinary retention | |
GB0018322D0 (en) | Pharmaceutical compositions | |
KR870005642A (en) | Mixture of Diflunisal and Tromethamine | |
JPS5780317A (en) | Preparation of pharmaceutical composition for injection | |
BR0113844A (en) | Use of arginine in the preparation of a drug to prevent and treat side effects associated with intravenous drug administration. | |
KR900005980A (en) | Anti-inflammatory α-[[(2-hydroxy-1,1-dimethyl-ethyl) amine] methyl] benzene methanol hydrochloride (EL-508) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20090603 |